Clinical trials and progress with paclitaxel in ovarian cancer

Paclitaxel is a front-line agent for ovarian cancer chemotherapy, along with the platinum agents. Derived from the Pacific yew tree, Taxus brevifolia, paclitaxel has covered significant ground from the initial discovery of its antineoplastic properties to clinical applications in many forms of human...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sanjeev, Mahdi, Haider, Bryant, Christopher, Shah, Jay P, Garg, Gunjal, Munkarah, Adnan
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024893/
https://www.ncbi.nlm.nih.gov/pubmed/21270965
http://dx.doi.org/10.2147/IJWH.S7012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024893/
https://www.ncbi.nlm.nih.gov/pubmed/21270965
http://dx.doi.org/10.2147/IJWH.S7012

Ejemplares similares